BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

234 related articles for article (PubMed ID: 35899119)

  • 1. Therapeutic Implications of FABP4 in Cancer: An Emerging Target to Tackle Cancer.
    Sun N; Zhao X
    Front Pharmacol; 2022; 13():948610. PubMed ID: 35899119
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Argininosuccinate synthase 1, arginine deprivation therapy and cancer management.
    Sun N; Zhao X
    Front Pharmacol; 2022; 13():935553. PubMed ID: 35910381
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CD36: an emerging therapeutic target for cancer and its molecular mechanisms.
    Ruan C; Meng Y; Song H
    J Cancer Res Clin Oncol; 2022 Jul; 148(7):1551-1558. PubMed ID: 35224665
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tumor resistance to ferroptosis driven by Stearoyl-CoA Desaturase-1 (SCD1) in cancer cells and Fatty Acid Biding Protein-4 (FABP4) in tumor microenvironment promote tumor recurrence.
    Luis G; Godfroid A; Nishiumi S; Cimino J; Blacher S; Maquoi E; Wery C; Collignon A; Longuespée R; Montero-Ruiz L; Dassoul I; Maloujahmoum N; Pottier C; Mazzucchelli G; Depauw E; Bellahcène A; Yoshida M; Noel A; Sounni NE
    Redox Biol; 2021 Jul; 43():102006. PubMed ID: 34030117
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Microenvironmental Factors Modulating Tumor Lipid Metabolism: Paving the Way to Better Antitumoral Therapy.
    Cai L; Ying M; Wu H
    Front Oncol; 2021; 11():777273. PubMed ID: 34888248
    [TBL] [Abstract][Full Text] [Related]  

  • 6. FABP4 in obesity-associated carcinogenesis: Novel insights into mechanisms and therapeutic implications.
    Liu S; Wu D; Fan Z; Yang J; Li Y; Meng Y; Gao C; Zhan H
    Front Mol Biosci; 2022; 9():973955. PubMed ID: 36060264
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Adipocytes promote cholangiocarcinoma metastasis through fatty acid binding protein 4.
    Nie J; Zhang J; Wang L; Lu L; Yuan Q; An F; Zhang S; Jiao Y
    J Exp Clin Cancer Res; 2017 Dec; 36(1):183. PubMed ID: 29237483
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Adipocyte Fatty-Acid Binding Protein is Overexpressed in Cirrhosis and Correlates with Clinical Outcomes.
    Graupera I; Coll M; Pose E; Elia C; Piano S; Solà E; Blaya D; Huelin P; Solé C; Moreira R; de Prada G; Fabrellas N; Juanola A; Morales-Ruiz M; Sancho-Bru P; Villanueva C; Ginès P
    Sci Rep; 2017 May; 7(1):1829. PubMed ID: 28500294
    [TBL] [Abstract][Full Text] [Related]  

  • 9. FABP4 promotes invasion and metastasis of colon cancer by regulating fatty acid transport.
    Tian W; Zhang W; Zhang Y; Zhu T; Hua Y; Li H; Zhang Q; Xia M
    Cancer Cell Int; 2020; 20():512. PubMed ID: 33088219
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fatty Acid-Binding Protein 4 in Cardiovascular and Metabolic Diseases.
    Furuhashi M
    J Atheroscler Thromb; 2019 Mar; 26(3):216-232. PubMed ID: 30726793
    [TBL] [Abstract][Full Text] [Related]  

  • 11. HIF1α-Regulated Expression of the Fatty Acid Binding Protein Family Is Important for Hypoxic Reactivation of Kaposi's Sarcoma-Associated Herpesvirus.
    Singh RK; Bose D; Robertson ES
    J Virol; 2021 May; 95(12):. PubMed ID: 33789996
    [TBL] [Abstract][Full Text] [Related]  

  • 12. FABP4 suppresses proliferation and invasion of hepatocellular carcinoma cells and predicts a poor prognosis for hepatocellular carcinoma.
    Zhong CQ; Zhang XP; Ma N; Zhang EB; Li JJ; Jiang YB; Gao YZ; Yuan YM; Lan SQ; Xie D; Cheng SQ
    Cancer Med; 2018 Jun; 7(6):2629-2640. PubMed ID: 29733540
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Targeted Inhibition of LPL/FABP4/CPT1 fatty acid metabolic axis can effectively prevent the progression of nonalcoholic steatohepatitis to liver cancer.
    Yang H; Deng Q; Ni T; Liu Y; Lu L; Dai H; Wang H; Yang W
    Int J Biol Sci; 2021; 17(15):4207-4222. PubMed ID: 34803493
    [No Abstract]   [Full Text] [Related]  

  • 14. Expression of fatty acid-binding protein-4 in gastrointestinal stromal tumors and its significance for prognosis.
    Zang WJ; Wang ZN; Hu YL; Huang H; Ma P
    J Clin Lab Anal; 2021 Nov; 35(11):e24017. PubMed ID: 34558731
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Exogenous FABP4 increases breast cancer cell proliferation and activates the expression of fatty acid transport proteins.
    Guaita-Esteruelas S; Bosquet A; Saavedra P; Gumà J; Girona J; Lam EW; Amillano K; Borràs J; Masana L
    Mol Carcinog; 2017 Jan; 56(1):208-217. PubMed ID: 27061264
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Adipose-Derived Fatty Acid-Binding Proteins Plasma Concentrations Are Increased in Breast Cancer Patients.
    Guaita-Esteruelas S; Saavedra-García P; Bosquet A; Borràs J; Girona J; Amiliano K; Rodríguez-Balada M; Heras M; Masana L; Gumà J
    Oncologist; 2017 Nov; 22(11):1309-1315. PubMed ID: 28701570
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The peritumoural adipose tissue microenvironment and cancer. The roles of fatty acid binding protein 4 and fatty acid binding protein 5.
    Guaita-Esteruelas S; Gumà J; Masana L; Borràs J
    Mol Cell Endocrinol; 2018 Feb; 462(Pt B):107-118. PubMed ID: 28163102
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Exogenous fatty acid binding protein 4 promotes human prostate cancer cell progression.
    Uehara H; Takahashi T; Oha M; Ogawa H; Izumi K
    Int J Cancer; 2014 Dec; 135(11):2558-68. PubMed ID: 24740818
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Elevated expression of FABP3 and FABP4 cooperatively correlates with poor prognosis in non-small cell lung cancer (NSCLC).
    Tang Z; Shen Q; Xie H; Zhou X; Li J; Feng J; Liu H; Wang W; Zhang S; Ni S
    Oncotarget; 2016 Jul; 7(29):46253-46262. PubMed ID: 27323829
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fatty acid binding protein 4 (FABP4) as a potential biomarker reflecting myocardial lipid storage in type 2 diabetes.
    Rodríguez-Calvo R; Girona J; Rodríguez M; Samino S; Barroso E; de Gonzalo-Calvo D; Guaita-Esteruelas S; Heras M; van der Meer RW; Lamb HJ; Yanes O; Correig X; Llorente-Cortés V; Vázquez-Carrera M; Masana L
    Metabolism; 2019 Jul; 96():12-21. PubMed ID: 30999003
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.